Next Article in Journal
Bioinspired Lipase Immobilized Membrane for Improving Hesperidin Lipophilization
Next Article in Special Issue
Health Benefits and Pharmacological Properties of Stigmasterol
Previous Article in Journal
Açaí (Euterpe oleracea Mart.) Attenuates Oxidative Stress and Alveolar Bone Damage in Experimental Periodontitis in Rats
Previous Article in Special Issue
Chelerythrine-Induced Apoptotic Cell Death in HepG2 Cells Involves the Inhibition of Akt Pathway and the Activation of Oxidative Stress and Mitochondrial Apoptotic Pathway
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Antioxidants
Volume 11
Issue 10
10.3390/antiox11101903
antioxidants-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Aniba canelilla (Kunth) Mez (Lauraceae) Essential Oil: Effects on Oxidative Stress and Vascular Permeability

by
Eloise K. Serrão Cardoso
1,†,
Karen Kubota
1,†,
Diandra Araújo Luz
1,
Paulo Fernando S. Mendes
2,
Pablo Luis B. Figueiredo
3,
Rafael Rodrigues Lima
2,
Cristiane S. Ferraz Maia
1 and
Enéas Andrade Fontes-Júnior
1,*
1
Laboratory of Pharmacology of Inflammation and Behavior, Faculty of Pharmacy, Institute of Health Science, Federal University of Pará, Belém 66075-110, PA, Brazil
2
Laboratory of Structural and Functional Biology, Institute of Biological Sciences, Federal University of Pará, Belém 66075-110, PA, Brazil
3
Natural Products Chemistry Laboratory, State University of Pará, Belém 66050-540, PA, Brazil
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to the work.
Antioxidants 2022, 11(10), 1903; https://doi.org/10.3390/antiox11101903
Submission received: 11 August 2022 / Revised: 2 September 2022 / Accepted: 4 September 2022 / Published: 26 September 2022
(This article belongs to the Special Issue Pharmacological Characterization of Natural Antioxidants)
Browse Figures
Versions Notes

Abstract

:
The present study aimed to investigate the antioxidant activity of Aniba canelilla (kunth) Mez (Lauraceae) essential oil (AcEO), exploring its potential for prevention and/or treatment of oxidative stress and associated inflammatory process. With this aim, Wistar rats (n = 6/group) were pre-treated intraperitoneally with saline (0.9%) or AcEO (2 or 5 mg/kg) for 5 days. One hour after the last dose, inflammation and oxidative stress were induced by carrageenan (0.3 mg/kg; ip.) administration. Total antioxidant capacity, reduced glutathione (GSH) and lipid peroxidation levels, protein concentration, and leukocyte migration were evaluated in peritoneal fluid. Lipid peroxidation was also evaluated in plasma. Carrageenan strongly reduced the peritoneal antioxidant capacity and GSH concentration, increasing peritoneal and plasma lipid peroxidation. It also promoted increased plasma leakage and leukocyte migration. Treatment with AcEO (2 and 5 mg/kg), whose major constituent was 1-nitro-2-phenylethane (77.5%), increased the peritoneal antioxidant capacity and GSH concentrations, and reduced lipid peroxidation, both peritoneal and plasma, thus inhibiting the carrageenan-induced oxidative imbalance. AcEO also reduced the carrageenan-induced plasma leakage and leukocyte migration. These data demonstrate the AcEO antioxidant activity and its ability to modulate plasma leakage and leukocyte migration, confirming its potential for treating diseases associated with inflammation and oxidative stress.

Graphical Abstract

1. Introduction

Free radicals, small molecules of unpaired free electrons, are largely produced during physiological metabolism and pathological processes. They perform important biological functions, such as defense against aggression, metabolism, energy production, fertilization, and gene activation [1,2], but they are also strongly associated with the genesis and evolution of many chronic and degenerative diseases [3,4]. Maintenance of homeostasis depends on a delicate balance between reactive species, primarily oxygen (ROS) and nitrogen (RNS), and systemic antioxidant mechanisms, which include enzymes such as Superoxide Dismutase (SOD), Catalase (CAT) and Glutathione Peroxidase (GPx), and non-enzymatic agents such as glutathione, alpha-tocopherol, and ascorbic acid [2,5].
Disruption of oxidative balance, caused by excessive production of ROS and RNS in combination or not with a decrease in enzymatic and non-enzymatic antioxidant activity, is known as oxidative stress. In this state, the oxidation process of biomolecules, such as lipids, proteins and nucleic acids, begins, generating functional and structural damages that compromise from cell activity and viability to functionality of tissues and organs, underlying which is the establishment of pathological conditions, usually chronic, such as inflammatory and degenerative diseases, obesity, diabetes, cardiovascular diseases, neoplasms, and neurological disorders [2,4].
The acquisition of such knowledge about oxidative stress influence on human illness has driven the search for strategies that promote systemic oxidative balance to prevent or treat pathological conditions. Ingestion of exogenous substances, mainly plant-derived products, including fruits, vegetables, cereals, flowers, or spices used for medicinal or food purposes, which scavenge free radicals, oxygen inhibitors and/or reducing agents, has shown great potential to decrease oxidative damage [6,7,8]. Aromatic plants, due to their secondary metabolites, such as polyphenols (phenolic acids, flavonoids, anthocyanins, lignans and stilbenes), carotenoids (xanthophylls and carotenes) and vitamins (vitamin E and C), demonstrate important antioxidant potential [6,9,10], in addition to anti-inflammatory, antibacterial, antiviral, antiaging and anticancer properties [11,12,13].
Within the great biodiversity and medicinal culture of the Amazon region, Aniba canelilla (Kunth) Mez [syn. Aniba elliptica A.C. Sm., Cryptocarya canelilla Kunth, and others], from Lauraceae family, an aromatic tree popularly known as ‘casca-preciosa’ (precious bark) or ‘falsa-canela’ (false cinnamon) stands out for its economic and medicinal potential [14,15]. Recognized for its characteristic cinnamon odor, attributed to its major constituent, 1-nitro-2-phenylethane (1N2F), A. canelilla is widely used in traditional medicine for the treatment of painful and inflammatory processes, in addition to gastrointestinal, neurological, and psychiatric disorders, and in the treatment of infections [16,17].
Given this potential, several studies have been conducted to verify the safety and efficacy of its use, having demonstrated the low toxicity of its essential oil (EO) (LD50 = 720 mg/kg, oral) and 1N2F (LD50 = 712 mg/kg, oral; and 490 mg/kg, ip.) in murine models [18,19,20]. Antinociceptive, anti-inflammatory [21,22,23,24,25,26], antihypertensive, bradycardic, anticonvulsant, anticholinesterase, anxiolytic and antibiotic activity against protozoa, fungi and bacteria have also been demonstrated [21,22,23,27,28,29,30]. Its antioxidant capacity has so far been verified only in physicochemical assays, in which its ability to scavenge DPPH (2,2-diphenyl-1-picrylhydrazyl) radicals was demonstrated [21]. In view of this, the present study aimed to investigate the antioxidant activity of A. canelilla essential oil (AcEO) in animal model, and to evaluate its application in prevention and/or treatment of oxidative stress and inflammatory processes correlated.

2. Materials and Methods

2.1. Chemicals and Reagents

Hexane (Chromatographic grade solvents), DTNB, TBA, ABTS, potassium persulfate and Trolox obtained from Sigma-Aldrich (Darmstadt, Germany). All chemicals used were of analytical grade. Indomethacin, Carrageenan Lambda C-3889, and Tween 80 (Sigma-Aldrich, St. Louis, MO, USA). Ketamine and Xylazine (Cristália, RJ, Brazil).

2.2. Animals

Male Wistar rats (n = 30), with an average weight of 150 g, from Federal University of Pará (UFPA) central vivarium, were kept in polypropylene cages (39 × 32 × 16 cm; up to 3/box) under standardized conditions of feeding and water (ad libitum), temperature (22 + 1 °C), exhaustion, and light/dark cycle (light from 6 a.m. to 6 p.m.). Experimental procedures were approved by UFPA’s Animal Research Ethics Committee (CEPAE; protocol No. 5320260521) and conducted in accordance with Care and Use of Laboratory Animals Guide (2011).

2.3. Plant Material, Extraction, and Analysis of Essential Oil

Leaves of a wild specimen of A. canelilla were collected in Belém, Pará state, Brazil (coordinates: 1°27′20.3″ S; 48°26′18.1″ W). Leaves were dried for seven days at room temperature, ground, and then submitted to EO extraction using a Clevenger-type apparatus (3 h) in triplicate. Then, oil was dried over anhydrous sodium sulfate, and the total oil yield was expressed as a percentual of the dried material. The specimen was collected in agreement with the Brazilian laws concerning the protection of biodiversity (SISGEN A704928).
EO was analyzed on a GCMS-QP2010 Ultra system (Shimadzu Corporation, Tokyo, Japan), equipped with an AOC-20i auto-injector and the GCMS-Solution system containing the Adams (2007) [31] and FFNSC 2 [32] libraries. A Rxi-5ms (30 m × 0.25 mm; 0.25 μm film thickness) silica capillary column (Restek Corporation, Bellefonte, PA, USA) was used. The conditions of analysis were: injector temperature of 250 °C; oven temperature programming of 60–240 °C (3 °C/min); helium as the carrier gas, adjusted to a linear velocity of 36.5 cm/s (1.0 mL/min); split mode injection for 1.0 μL of the sample (oil 3.0 μL: hexane 500 μL); split ratio 1:20; ionization by electronic impact at 70 eV; ionization source and transfer line temperatures of 200 and 250 °C, respectively. Mass spectra were obtained by automatically scanning every 0.3 s, with mass fragments in the range of 35–400 m/z. The retention index was calculated for all volatile components using a homologous series of C8-C40 n-alkanes (Sigma-Aldrich, St. Louis, MO, USA), according to the linear equation of van den Dool and Kratz (1963) [33]. Quantitative data regarding the volatile constituents were obtained by peak-area normalization using a GC 2010 Plus Series, coupled with an FID Detector, operated under similar conditions to the GC-MS system.

2.4. Drugs and Solutions

Carrageenan (0.3 mg/kg) and Indomethacin (10 mg/kg) solutions were prepared in saline (0.9%). AcEO (density = 1.020 g/mL) was prepared at doses of 2 and 5 mg/kg [20,26], being solubilized in sterile saline (0.9%), with the addition of tween 80 (1%). Drugs were administered intraperitoneally (ip.), with a standard volume of 0.1 mL/100 g of body weight.

2.5. Carrageenan-Induced Peritonitis

According to Souza and Ferreira (1985) [34] protocol, inflammation and consequent oxidative stress were induced in the peritoneal cavity by carrageenan (0.3 mg/kg) administration. For this, animals were randomly distributed into five groups (n = 6/group), which were previously treated for five days with saline (White and Carrageenan Groups), AcEO (2.0 or 5.0 mg/kg), or Indomethacin (10 mg/kg). Carrageenan was administered 1 h after the last pretreatment dose.
Four hours later, animals were euthanized under anesthesia (ketamine + xylazine; 91 + 9.1 mg/kg; ip.), after which 5 mL of saline were injected into peritoneal cavity, and the wash was collected to oxidative balance and leukocyte migration evaluation. Blood samples were also collected by cardiac puncture, and then centrifuged (3500 RPM for 10 min) for plasma separation, for the assessment of the oxidative balance (Figure 1).

2.6. Oxidative Biochemistry Assays

2.6.1. Total Antioxidant Capacity

Trolox equivalent antioxidant capacity (TEAC) was evaluated through the reaction between ABTS and potassium persulfate (K2S2O8), producing the cationic radical ABTS•+ (3-ethylbenzothiazoline-6-sulfonate, diammonium salt), as proposed by Re et al. (1999) [35]. Antioxidant compounds reduce the formed radical back to ABTS, which can be measured by spectrophotometry (λ = 734 ηm). The AcEO ability to reduce radicals was evaluated 5 min from addition of 30 μL of sample in 2970 μL of ABTS•+. Results expressed as Trolox equivalent (μmol/mL).

2.6.2. Reduced Glutathione Level (GSH)

Were evaluated their ability to reduce 5,5-dithiobis-2-nitrobenzoic acid (DTNB) to (TNB). First, 20 μL of sample, deproteinized with trichloroacetic acid (2%), was placed in 20 μL of distilled water and 3 mL of SOD buffer, and then read in a spectrophotometer (λ = 412 ηm) [36]. Then, 100 μL of DTNB was added, allowed to react for 3 min, and read again. GSH concentration was calculated using a standard curve and expressed in μg/mL.

2.6.3. Lipid Peroxidation

It was evaluated from the reaction of polyunsaturated fatty acids metabolites, products of lipid peroxidation, with thiobarbituric acid, which produces measurable staining by spectrophotometry (λ = 535 nm) [37,38]. For this, 100 μL of the sample was mixed with 500 μL of thiobarbituric acid (10 ηM), and heated at 94 °C for 60 min in a water bath. The solution was cooled for 10 min, then 2 mL of l-butyl alcohol was added, followed by centrifugation (2500 rpm for 10 min) and collection of 1 mL of the supernatant, which was read in a spectrophotometer. Results were expressed as thiobarbituric acid reactive substances (TBARS) concentration, calculated using standard curve, in ηmol/mL.

2.7. Vascular Permeability Assays

2.7.1. Protein Concentration

Doles total protein colorimetric kit was used, as proposed by Gornall (1949) [39]. In this way, 50 μL of peritoneal lavage was added to 2.5 mL of Biureto (0.114 M Trisodium Citrate; 0.21 M Sodium Carbonate, and 0.01 M Copper Sulfate). Two drops of sodium hydroxide (500 mmol/L) were then added, and reading was taken in a spectrophotometer (λ = 550 ηm). Bovine albumin (40 mg/mL) was used as standard, and results are expressed in mg/mL.

2.7.2. Cell Migration Assessment

This was evaluated through the total leukocyte count in peritoneal lavage. For this, 20 µL of sample was diluted in 380 µL of Turk’s solution. Counting was performed in Neubauer chamber by optical microscopy (400× magnification). Results expressed as number of cells/mL.

2.8. Statistical Analysis

Data normality was assessed using the Shapiro–Wilk method. The difference between groups was verified by one-way ANOVA, followed by Dunnett’s test, when data presented Gaussian distribution; and Kruskal–Wallis test, followed by Dunn’s test, in other cases. Differences with p < 0.05 were considered statistically significant.

3. Results

3.1. Essential Oil Composition

The oil yield was 1.3 ± 0.1%. Benzenoid class (80.0 ± 5.8) were predominant in AcEO, and a low amount of oxygenated sesquiterpenes (6.9 ± 1.6%), sesquiterpene hydrocarbons (6.9 ± 4.7), monoterpene hydrocarbons (1.0 ± 0.9%), and oxygenated (3.5 ± 1.0%) were detected (Table 1).
Thirty-two compounds were identified, and the major compound was 1-nitro-2-phenylethane (1N2F), accounting for 77.5 ± 4.8%. Other compounds were detected in minor amounts, such as E-caryophyllene (3.6%), linalool (2.8 ± 0.7%), β-longipinene (1.6 ± 0.9%), and benzene acetaldehyde (1.1 ± 0.1%). The chromatograms of AcEO are shown in Figure 2.

3.2. AcEO Antioxidant Activity

3.2.1. AcEO Improves Total Antioxidant Capacity

Intraperitoneal administration of carrageenan (0.3 mg/kg) significantly reduced the total antioxidant capacity of peritoneal fluid when compared to white group (0.27 ± 0.02 μmol/mL and 0.85 ± 0.15 μmol/mL, respectively; p < 0.01). Pretreatment with AcEO (2 and 5 mg/kg; ip.) was able to prevent this effect (p < 0.05), generating a result (0.61 ± 0.07 μmol/mL and 0.76 ± 0.20 μmol/mL, respectively) comparable to white group (p = 1.00 to both; Figure 3).

3.2.2. AcEO Prevents GSH Decrease

Carrageenan (0.3 mg/kg; ip.) promoted a significant decrease in peritoneal fluid GSH levels when compared to white group (14.59 ± 1.26 μg/mL and 65.59 ± 17.06 μg/mL, respectively; p = 0.002). AcEO treatment (2.0 and 5.0 mg/kg; ip.) was able to prevent GSH decrease (41.27 ± 7.67 μg/mL and 49.06 ± 17.45 μg/mL, respectively), which maintained levels equivalent to white group (p = 1.00 for both; Figure 4).

3.2.3. AcEO Prevents Lipid Peroxidation

A significant increase in TBARS levels (p < 0.001), both in peritoneal fluid (Figure 5A) and in plasma (Figure 5B), was observed in animals that received carrageenan (0.3 mg/kg; ip.), when compared to white group (peritoneal fluid—9.61 ± 0.30 ηmol/mL and 3.29 ± 0.94 ηmol/mL, respectively; plasma—15.44 ± 0.76 ηmol/mL and 6.37 ± 0.74 ηmol/mL, respectively). On the other hand, AcEO treatment (2.0 and 5.0 mg/kg; ip.) was able to reduce TBARS concentration (peritoneal fluid–4.03 ± 0.63 ηmol/mL and 4.95 ± 1.26 ηmol/mL, respectively; plasma–6.08 ± 0.99 ηmol/mL and 7.03 ± 0.78 ηmol/mL, respectively) to white group equivalent levels (p < 0.001 for both; Figure 5).

3.3. AcEO Activity on Vascular Permeability

3.3.1. AcEO Inhibits Plasma Leakage into Peritoneal Cavity

A significant increase was observed in peritoneal fluid proteins concentration of the animals that received carrageenan (0.3 mg/kg; ip.), when compared to the white group (300 ± 65,47 mg/mL and 1517.86 ± 126.69 mg/mL, respectively; p < 0.001). In peritoneal fluid of animals treated with AcEO (2.0 and 5.0 mg/kg; ip.), an inhibition of this elevation was observed (592.86 ± 137.67 mg/mL and 491.07 ± 132.33 mg/kg, respectively), showing protein levels equivalent to white group (p = 0.385 and 0.760, respectively). The oil effect was also like non-steroidal anti-inflammatory indomethacin (p = 0.371 and 0.643, respectively) (Figure 6).

3.3.2. AcEO Reduces Leukocyte Migration into the Peritoneal Cavity

Carrageenan administration induced a significant increase in peritoneal fluid leukocyte count (11.32 ± 1.05 × 106) when compared to white group (3.94 ± 0.25 × 106). Treatment with AcEO (2.0 and 5.0 mg/kg), however, inhibited carrageenan-induced leukocyte migration (6.42 ± 0.81 × 106 and 6.78 ± 1.49 × 106), promoting levels equivalent to those of indomethacin (6.7 ± 1.18 × 106) (Figure 7).

4. Discussion

The present study demonstrates for the first time the effect of AcEO on oxidative balance and vascular permeability in a murine model. The research was conceived on the basis of the identification of gaps in knowledge about the pharmacological properties of A. canelilla, widely diffused in Amazonian medicinal culture, being used for the treatment of inflammatory, painful processes and affections of the digestive, respiratory, and central nervous systems. In a recent review developed by our group [30], the potential of this aromatic plant for the development of innovative therapeutic agents was discussed; however, knowledge about its properties is still scarce, especially with respect to its antioxidant properties, had up until that point been limited to physicochemical assays, which sought to demonstrate its ability to scavenge free radicals. There was also a lack of data regarding its effects on vascular permeability. Our findings demonstrated that AcEO has significant antioxidant activity in a stress context, in addition to modulating vascular permeability.
AcEO yield and composition can vary significantly depending on geographic region and seasonal collection period, as well as the part of the plant from which it is extracted [40]. However, studies so far have shown that EO extracted from leaves does not exhibit yield variation as a function of seasonality [41]. Taveira et al. [41] showed a yield variation between 0.5 and 0.8% in EO extracted from leaves, which was related to soil type. In our study, the EO extracted from leaves collected in May, the rainy season [42], showed a yield of 1.3%.
Regarding its composition, it has been described that EO extracted from leaves has the highest concentrations of 1N2F, ranging from 39% (dry periods) to 95% (rainy periods) [41]. Our sample, collected during the rainy season, presented a 1N2F content of 77.5%. The main bioactive AcEO properties, including anti-inflammatory and antinociceptive, were attributed to this benzenoid, recognized by its characteristic cinnamon-like odor [19,21,22,23,24,25].
Inflammation and oxidative stress are closely related mechanisms that are both part of the immune response and are also associated with the genesis and evolution of several pathologies. Therefore, considering the AcEO and its main potential component, the carrageenan-induced peritonitis model was adopted, since it induces inflammation, linked to marked oxidative stress [43,44].
The cavitary response triggered by intraperitoneal carrageenan (0.3 mg/kg) administration is marked by the phasic release of inflammatory mediators, such as histamine, serotonin, kinins and prostanoids, as well as ROS/RNS production [43,44,45]. Consequently, increases in vascular permeability and leukocyte migration and activation are observed, which also enhances the ROS/RNS production [43]. These, in turn, positively modulate the necrosis factor κB (NFκB), a key transcription factor of inflammatory response [46].
In this complex process, the excessive production of ROS, such as hydroxyl (•OH) and superoxide (O2•−) radicals, is triggered, together with increased nitric oxide (NO) synthesis, through the activation of induced nitric oxide synthase (iNOS). The reaction between these species can also lead to the formation of the peroxynitrite (ONOO−) radical, which together generate lipid peroxidation, protein carbonylation and DNA damage, contributing to cell dysfunction and death [4,5,47]
Its intensity can be measured indirectly, through the consumption of antioxidant agents, such as GSH, a thiol tripeptide (γ-L-glutamyl-L-cysteinylglycine), which protects cells from oxidative damage by interacting with and neutralizing reactive species [2,48,49]. In fact, a reduction in total peritoneal fluid antioxidant capacity of about 69% was observed, as well as a drop in GSH concentration of about 78%, in animals administered with carrageenan, evidencing the consumption of antioxidant agents due to reactive species overload.
The extent of oxidative damage generated was evaluated by measuring the secondary products of lipid hydroperoxides, such as hyroxinonenal and malonaldehyde (MDA), which are involved in mutagenic processes, atherogenic lesions and neurodegenerative disorders, by its reaction with thiobarbituric acid [3,4,11,46,47]. Animals administered carrageenan had intraperitoneal levels of these TBARS about 2.9 times higher than those in the white group. In plasma, the elevation was around 2.4 times.
In this scenario, treatment with AcEO proved to be effective for preventing the oxidative stress and consequent damages induced by carrageenan, since the animals treated with the EO showed a total antioxidant capacity statistically equivalent to the white group. Conjointly, the AcEO increased the concentration of GSH in the peritoneal fluid and reduced the levels of TBARS in peritoneal fluid and plasma, producing results equivalent to the white group (which was not administered with carrageenan). These findings demonstrate the oil’s ability to reduce oxidative stress by improving the GSH contingent and inhibiting lipid peroxidation induced by carrageenan.
Da Silva et al. (2007) [21] demonstrated, in a physical–chemical test, that the AcEO extracted from the trunk wood and 1N2F are capable of neutralizing DPPH radicals, which may indicate that effects observed in present study are related to scavenging activity of its constituents. Other minor components present in the AcEO sample, such as caryophyllene oxide (4.4%) and Linalool (2.8%), have also been described as antioxidants, as they scavenge free radicals, inhibit NO production, or increase systemic antioxidants, such as GSH [50,51], which may contribute to the observed antioxidant activity.
The neutralization of ROS could explain the preservation of GSH concentration at levels similar to the white group, since it would inhibit its consumption [52,53]. This same principle justifies the preservation of total antioxidant activity. However, possible inhibitory effects on ROS-generating enzymes, such as xanthine oxidase, or the stimulation of antioxidant enzymes, should not be ruled out.
The interface between inflammation and oxidative stress amplification, as observed in carrageenan-induced peritonitis, is closely related to increased peritoneal vascular permeability and leukocyte migration. In fact, in line with the literature, this study demonstrated an increase in peritoneal fluid proteins concentration, an indicator of an increase in plasma leakage, associated with an increase in the number of leukocytes, which, as previously described, is related to both the inflammatory mediators release through p38/MARK/NFκB myeloperoxidase way activation, as with the production of ROS [54].
Vale et al. (2013) [25] demonstrated the anti-inflammatory activity of 1N2F, reducing edema induced by croton oil, carrageenan, or dextran, pointing out the possible interaction with prostaglandin endoperoxide synthase as mechanism of action. In the present study, however, its inhibitory activity on vascular permeability and leukocyte migration was demonstrated for the first time.
The combination of anti-inflammatory and antioxidant activities highlights the potential of AcEO and its major constituent, 1N2F, for the development of innovative therapeutic agents aimed at the treatment of inflammatory, chronic and degenerative diseases associated with oxidative stress.

5. Conclusions

In summary, our results show that AcEO, made up mostly of 1N2F, is endowed with outstanding antioxidant activity, possibly associated, at least in part, with its ability to scavenge free radicals. Its ability to modulate vascular permeability was also exposed, inhibiting plasma leakage and leukocyte migration, demonstrating its potential for the development of natural products aimed at the treatment of inflammatory conditions associated with oxidative stress.

Author Contributions

Conceptualization, E.A.F.-J.; Formal analysis, E.K.S.C., K.K., D.A.L., P.F.S.M., P.L.B.F., R.R.L., C.S.F.M. and E.A.F.-J.; Investigation, E.K.S.C., K.K., D.A.L., P.F.S.M., P.L.B.F., R.R.L., C.S.F.M. and E.A.F.-J.; Methodology, E.K.S.C., K.K. and E.A.F.-J.; Supervision, D.A.L., P.L.B.F. and E.A.F.-J.; Writing—original draft, E.K.S.C., K.K. and E.A.F.-J.; Writing—review and editing, E.K.S.C., K.K., P.L.B.F. and E.A.F.-J. All authors have read and agreed to the published version of the manuscript.

Funding

Research Pro-Rectory of the Federal University of Pará (PROPESP, UFPA, Brazil) provided research initiation grant to Eloise K. Serrão Cardoso (grant number 10/2021.2-PROPESP) and the article publication fee (funding number 02/2022-PROPESP).

Institutional Review Board Statement

This study was conducted according to the guideline/s of the Care and Use of Laboratory Animals Guide (2011), approved by the Ethics Committee of the Federal University of Pará, Belém, Brazil (date: 24 June 2021; code: 5320260521).

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Jones, D.P. Radical-free biology of oxidative stress. Am. J. Physiol. Cell Physiol. 2008, 295, C849–C868. [Google Scholar] [PubMed]
  2. Forman, H.J.; Zhang, H. Targeting oxidative stress in disease: Promise and limitations of antioxidant therapy. Nat. Rev. Drug Discov. 2021, 20, 689–709. [Google Scholar] [PubMed]
  3. Feitosa, C.M.; da Silva Oliveira, G.L.; do Nascimento Cavalcante, A.; Morais Chaves, S.K.; Rai, M. Determination of parameters of oxidative stress in vitro models of neurodegenerative diseases—A review. Curr. Clin. Pharmacol. 2018, 13, 100–109. [Google Scholar] [CrossRef] [PubMed]
  4. Sharapov, M.G.; Gudkov, S.V.; Lankin, V.Z.; Novoselov, V.I. Role of Glutathione Peroxidases and Peroxiredoxins in Free Radical-Induced Pathologies. Biochemistry 2021, 86, 1418–1433. [Google Scholar]
  5. Filomeni, G.; de Zio, D.; Cecconi, F. Oxidative stress and autophagy: The clash between damage and metabolic needs. Cell Death Differ. 2015, 22, 377–388. [Google Scholar]
  6. Baiano, A.; del Nobile, M.A. Antioxidant compounds from vegetable matrices: Biosynthesis, occurrence, and extraction systems. Crit. Rev. Food Sci. Nutr. 2016, 56, 2053–2068. [Google Scholar]
  7. Li, A.-N.; Li, S.; Li, H.-B.; Xu, D.-P.; Xu, X.-R.; Chen, F. Total phenolic contents and antioxidant capacities of 51 edible and wild flowers. J. Funct. Foods 2014, 6, 319–330. [Google Scholar] [CrossRef]
  8. Li, Y.; Zhang, J.-J.; Xu, D.-P.; Zhou, T.; Zhou, Y.; Li, S.; Li, H.-B. Bioactivities and health benefits of wild fruits. Int. J. Mol. Sci. 2016, 17, 1258. [Google Scholar] [CrossRef] [PubMed]
  9. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: Food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79, 727–747. [Google Scholar]
  10. Xu, D.-P.; Li, Y.; Meng, X.; Zhou, T.; Zhou, Y.; Zheng, J.; Zhang, J.-J.; Li, H.-B. Natural antioxidants in foods and medicinal plants: Extraction, assessment and resources. Int. J. Mol. Sci. 2017, 18, 96. [Google Scholar] [CrossRef]
  11. Zhang, Y.-J.; Gan, R.-Y.; Li, S.; Zhou, Y.; Li, A.-N.; Xu, D.-P.; Li, H.-B. Antioxidant phytochemicals for the prevention and treatment of chronic diseases. Molecules 2015, 20, 21138–21156. [Google Scholar] [PubMed]
  12. Balmus, I.M.; Ciobica, A.; Trifan, A.; Stanciu, C. The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models. Saudi J. Gastroenterol. Off. J. Saudi Gastroenterol. Assoc. 2016, 22, 3. [Google Scholar] [CrossRef] [PubMed]
  13. Jenab, M.; Riboli, E.; Ferrari, P.; Sabate, J.; Slimani, N.; Norat, T.; Friesen, M.; Tjønneland, A.; Olsen, A.; Overvad, K. Plasma and dietary vitamin C levels and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Carcinogenesis 2006, 27, 2250–2257. [Google Scholar] [CrossRef]
  14. Pinto, A.C. O Brasil dos viajantes e dos exploradores e a química de produtos naturais brasileira. Química Nova 1995, 18, 608–615. [Google Scholar]
  15. Tropicos.org. Missouri Botanical Garden. Available online: https://www.tropicos.org/name/17800123 (accessed on 13 July 2022).
  16. Maia, J.G.S.; Zoghbi, M.; das, G.B.; de Aguilar Andrade, E.H. Plantas Aromáticas na Amazônia e Seus Óleos Essenciais; Museu Paraense Emílio Goeldi: Belem, PA, Brazil, 2001. [Google Scholar]
  17. Almeida, F.F. Estudo de Revisão da Literatura Sobre a Importância do Óleo Essencial de Aniba Canelilla e Estudo Experimental da Biotransformação do 1-Nitro-2-Feniletano; UNIFESSPA: Marabá, Brazil, 2022. [Google Scholar]
  18. Sousa, P.J.C.; Araujo, J.S.; Pereira, L.L.S.; Modro, M.N.R.; Maia, J.G.S.; Araujo, M.T.F.; Carvalho, J.C.T.; Perazzo, F.F. Phytochemical and Toxicological Evaluations of the Essential Oil From the Bark of Aniba canellila (HBK) Mez. J. Essent. Oil Res. 2009, 21, 381–384. [Google Scholar] [CrossRef]
  19. de Lima, A.B.; Santana, M.B.; Cardoso, A.S.; da Silva, J.K.R.; Maia, J.G.S.; Carvalho, J.C.T.; Sousa, P.J.C. Antinociceptive activity of 1-nitro-2-phenylethane, the main component of Aniba canelilla essential oil. Phytomedicine 2009, 16, 555–559. [Google Scholar] [CrossRef]
  20. Oyemitan, I.A.; Elusiyan, C.A.; Akanmu, M.A.; Olugbade, T.A. Hypnotic, anticonvulsant and anxiolytic effects of 1-nitro-2-phenylethane isolated from the essential oil of Dennettia tripetala in mice. Phytomedicine 2013, 20, 1315–1322. [Google Scholar] [CrossRef]
  21. Da Silva, J.K.R.; Sousa, P.J.C.; Andrade, E.H.A.; Maia, J.G.S. Antioxidant capacity and cytotoxicity of essential oil and methanol extract of Aniba canelilla (HBK) Mez. J. Agric. Food Chem. 2007, 55, 9422–9426. [Google Scholar] [CrossRef] [PubMed]
  22. Da Silva, G.F. Estudo do Potencial Biotecnológico de Aniba Canelilla (HBK) Mez Para Obtenção de Cosméticos; Universidade do Estado do Amazonas: Manaus, Brazil, 2012. [Google Scholar]
  23. Mesquita, T.J.B.; da Silva, G.F.; Albuquerque, P.M.; Duvoisin, S., Jr. Análise fitoquímica e determinação da capacidade antioxidante em extratos de Aniba canelilla (HBK) Mez. In Anais Do XX Congresso Brasileiro de Engenharia Química; Blucher Chemical Engineering Proceedings: Florianópolis, SC, Brazil, 2014; Volume 8. [Google Scholar]
  24. Martins, F.J.; Caneschi, C.A.; Vieira, J.L.F.; Barbosa, W.; Raposo, N.R.B. Antioxidant activity and potential photoprotective from amazon native flora extracts. J. Photochem. Photobiol. B Biol. 2016, 161, 34–39. [Google Scholar] [CrossRef]
  25. Vale, J.K.L.; Lima, A.B.; Pinheiro, B.G.; Cardoso, A.S.; Silva, J.K.R.; Maia, J.G.S.; de Sousa, G.E.P.; da Silva, A.B.F.; Sousa, P.J.C.; Borges, R.S. Evaluation and theoretical study on the anti-inflammatory mechanism of 1-nitro-2-phenylethane. Planta Med. 2013, 79, 628–633. [Google Scholar] [CrossRef]
  26. Lahlou, S.; Magalhães, P.J.C.; de Siqueira, R.J.B.; Figueiredo, A.F.; Interaminense, L.F.L.; Maia, J.G.S.; da Cunha Sousa, P.J. Cardiovascular effects of the essential oil of Aniba canelilla bark in normotensive rats. J. Cardiovasc. Pharmacol. 2005, 46, 412–421. [Google Scholar] [CrossRef] [PubMed]
  27. De Siqueira, R.J.B.; Macedo, F.I.B.; de Fátima LealInteraminense, L.; Duarte, G.P.; Magalhães, P.J.C.; Brito, T.S.; da Silva, J.K.R.; Maia, J.G.S.; da CunhaSousa, P.J.; Leal-Cardoso, J.H.; et al. 1-Nitro-2-phenylethane, the main constituent of the essential oil of Aniba canelilla, elicits a vago-vagal bradycardiac and depressor reflex in normotensive rats. Eur. J. Pharmacol. 2010, 638, 90–98. [Google Scholar] [CrossRef]
  28. de Fátima Leal Interaminense, L.; de Siqueira, R.J.B.; Xavier, F.E.; Duarte, G.P.; Magalhães, P.J.C.; da Silva, J.K.; Maia, J.G.S.; da Cunha Sousa, P.J.; Leal-Cardoso, J.H.; Lahlou, S. Cardiovascular effects of 1-nitro-2-phenylethane, the main constituent of the essential oil of Aniba canelilla, in spontaneously hypertensive rats. Fundam. Clin. Pharmacol. 2011, 25, 661–669. [Google Scholar] [CrossRef] [PubMed]
  29. Halliwell, B.; Cross, C.E. Oxygen-derived species: Their relation to human disease and environmental stress. Environ. Health Perspect. 1994, 102 (Suppl. S10), 5–12. [Google Scholar]
  30. Souza-Junior, F.J.C.; Luz-Moraes, D.; Pereira, F.S.; Barros, M.A.; Fernandes, L.M.P.; Queiroz, L.Y.; Maia, C.F.; Maia, J.G.S.; Fontes-Junior, E.A. Aniba canelilla (Kunth) mez (Lauraceae): A review of ethnobotany, phytochemical, antioxidant, anti-inflammatory, cardiovascular, and neurological properties. Front. Pharmacol. 2020, 11, 699. [Google Scholar] [CrossRef]
  31. Adams, R.P. Identification of Essential Oil Components by Gas Chromatography/Mass Spectrometry; Allured Publishing Corporation: Carol Stream, IL, USA, 2007; Volume 456. [Google Scholar]
  32. Mondello, L. FFNSC Library—Mass Spectra of Flavors and Fragrances of Natural and Synthetic Compounds; Shimadzu Corporation: Kyoto, Japan, 2011. [Google Scholar]
  33. Van den Dool, H.; Kratz, P.D. A Generalization of The Retention Index System Including Linear Temperature Programmed Gas-Liquid Partition Chromatography. J. Chromatogr. A 1963, 11, 463–471. [Google Scholar] [CrossRef]
  34. De Souza, G.E.P.; Ferreira, S.H. Blockade by antimacrophage serum of the migration of PMN neutrophils into the inflamed peritoneal cavity. Agents Actions 1985, 17, 97–103. [Google Scholar] [CrossRef]
  35. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 1999, 26, 1231–1237. [Google Scholar] [CrossRef]
  36. George, E.L. Tissue sulfhydryl groups. Arch. Biochem Biophys 1959, 82, 70–77. [Google Scholar]
  37. Kohn, H.I.; Liversedge, M. On a new aerobic metabolite whose production by brain is inhibited by apomorphine, emetine, ergotamine, epinephrine, and menadione. J. Pharmacol. Exp. Ther. 1994, 82, 292–300. [Google Scholar]
  38. Percario, S.; Vital, A.C.C.; Jablonka, F. Dosagem do malondialdeido. Newslab 1994, 2, 46–50. [Google Scholar]
  39. Gornall, A.G.; Bardawill, C.J.; David, M.M. Determination of serum proteins by means of the Biuret reaction. J. Biol. Chem. 1949, 177, 751–766. [Google Scholar] [CrossRef]
  40. Manhães, A.P.; da Veiga-Júnior, V.F.; Wiedemann, L.S.M.; Fernandes, K.S.; de Tarso Barbosa Sampaio, P. Biomass production and essential oil yield from leaves, fine stems and resprouts using pruning the crown of Aniba canelilla (HBK) (Lauraceae) in the Central Amazon. Acta Amaz. 2012, 42, 355–362. [Google Scholar] [CrossRef]
  41. Taveira, F.S.N.; de Lima, W.N.; Andrade, E.H.A.; Maia, J.G.S. Seasonal essential oil variation of Aniba canelilla. Biochem. Syst. Ecol. 2003, 31, 69–75. [Google Scholar] [CrossRef]
  42. De Moraes, B.C.; da Costa, J.M.N.; da Costa, A.C.L.; Costa, M.H. Variação espacial e temporal da precipitação no estado do Pará. Acta Amaz. 2005, 35, 207–214. [Google Scholar] [CrossRef]
  43. Markov, A.V.; Sen’kova, A.V.; Babich, V.O.; Odarenko, K.V.; Talyshev, V.A.; Salomatina, O.V.; Salakhutdinov, N.F.; Zenkova, M.A.; Logashenko, E.B. Dual effect of soloxolone methyl on LPS-induced inflammation in vitro and in vivo. Int. J. Mol. Sci. 2020, 21, 7876. [Google Scholar] [CrossRef]
  44. Falcão, T.R.; de Araújo, A.A.; Soares, L.A.L.; de Farias, I.B.; da Silva, W.A.V.; Ferreira, M.R.A.; de Araújo, R.F., Jr.; de Medeiros, J.S.; de Sousa Lopes, M.L.D.; Guerra, G.C.B. Libidibia ferrea fruit crude extract and fractions show anti-inflammatory, antioxidant, and antinociceptive effects in vivo and increase cell viability in vitro. Evid. Based Complementary Altern. Med. 2019, 2019, 6064805. [Google Scholar]
  45. Amorim, V.R.; do Nascimento Rodrigues, D.C.; do Nascimento Silva, J.; Ramos, C.L.S.; Almeida, L.M.N.; Almeida, A.A.C.; Pinheiro-Neto, F.R.; Almeida, F.R.C.; Rizzo, M.S.; Pereira-Freire, J.A. Anti-inflammatory mechanisms of fruits and by-products from Mauritia flexuosa, an exotic plant with functional benefits. J. Toxicol. Environ. Health 2021, 84, 441–457. [Google Scholar] [CrossRef] [PubMed]
  46. Mitrea, D.R.; Malkey, R.; Florian, T.L.; Filip, A.; Clichici, S.; Bidian, C.; Moldovan, R.; Hoteiuc, O.A.; Toader, A.M.; Baldea, I. Daily oral administration of chlorogenic acid prevents the experimental carrageenan-induced oxidative stress. J. Physiol Pharm. 2020, 71, 55–65. [Google Scholar]
  47. Förstermann, U.; Sessa, W.C. Nitric oxide synthases: Regulation and function. Eur. Heart J. 2012, 33, 829–837. [Google Scholar] [CrossRef] [PubMed]
  48. Zalachoras, I.; Hollis, F.; Ramos-Fernández, E.; Trovo, L.; Sonnay, S.; Geiser, E.; Preitner, N.; Steiner, P.; Sandi, C.; Morató, L. Therapeutic potential of glutathione-enhancers in stress-related psychopathologies. Neurosci. Biobehav. Rev. 2020, 114, 134–155. [Google Scholar] [CrossRef]
  49. Bjørklund, G.; Peana, M.; Maes, M.; Dadar, M.; Severin, B. The glutathione system in Parkinson’s disease and its progression. Neurosci. Biobehav. Rev. 2021, 120, 470–478. [Google Scholar] [CrossRef] [PubMed]
  50. Coté, H.; Boucher, M.-A.; Pichette, A.; Legault, J. Anti-inflammatory, antioxidant, antibiotic, and cytotoxic activities of Tanacetum vulgare L. essential oil and its constituents. Medicines 2017, 4, 34. [Google Scholar] [CrossRef]
  51. Mehri, S.; Meshki, M.A.; Hosseinzadeh, H. Linalool as a neuroprotective agent against acrylamide-induced neurotoxicity in Wistar rats. Drug Chem. Toxicol. 2015, 38, 162–166. [Google Scholar] [CrossRef] [PubMed]
  52. Fraga, C.G.; Oteiza, P.I.; Galleano, M. In vitro measurements and interpretation of total antioxidant capacity. Biochim. Et Biophys. Acta Gen. Subj. 2014, 1840, 931–934. [Google Scholar] [CrossRef] [PubMed]
  53. Liu, Q.; Tang, G.-Y.; Zhao, C.-N.; Feng, X.-L.; Xu, X.-Y.; Cao, S.-Y.; Meng, X.; Li, S.; Gan, R.-Y.; Li, H.-B. Comparison of antioxidant activities of different grape varieties. Molecules 2018, 23, 2432. [Google Scholar] [CrossRef]
  54. Gomes Junior, A.L.; Islam, M.T.; Nicolau, L.A.D.; de Souza, L.K.M.; de Souza Lopes Araújo, T.; de Oliveira, G.A.L.; de Melo Nogueira, K.; da Silva Lopes, L.; Medeiros, J.-V.R.; Mubarak, M.S. Anti-inflammatory, antinociceptive, and antioxidant properties of anacardic acid in experimental models. ACS Omega 2020, 5, 19506–19515. [Google Scholar] [CrossRef] [PubMed]
Antioxidants 11 01903 g001 550
Figure 1. Experimental design. * Anti-inflammatory standard.
Figure 1. Experimental design. * Anti-inflammatory standard.
Antioxidants 11 01903 g001
Antioxidants 11 01903 g002 550
Figure 2. Aniba canelilla essential oil chromatogram.
Figure 2. Aniba canelilla essential oil chromatogram.
Antioxidants 11 01903 g002
Antioxidants 11 01903 g003 550
Figure 3. Effect of Aniba canelilla essential oil (AcEO; 2.0 and 5.0 mg/kg; ip.) on the total antioxidant capacity of the peritoneal fluid of rats submitted to carrageenan (CARR)-induced (0.3 mg/kg) peritonitis. Data expressed as mean ± SEM (n = 6/group). ++ p < 0.01 vs. white group; * p < 0.05 vs. CARR group. Kruskal–Wallis followed by Dunn’s test.
Figure 3. Effect of Aniba canelilla essential oil (AcEO; 2.0 and 5.0 mg/kg; ip.) on the total antioxidant capacity of the peritoneal fluid of rats submitted to carrageenan (CARR)-induced (0.3 mg/kg) peritonitis. Data expressed as mean ± SEM (n = 6/group). ++ p < 0.01 vs. white group; * p < 0.05 vs. CARR group. Kruskal–Wallis followed by Dunn’s test.
Antioxidants 11 01903 g003
Antioxidants 11 01903 g004 550
Figure 4. Effect of Aniba canelilla essential oil (AcEO; 2.0 and 5.0 mg/kg; ip.) on peritoneal fluid GSH concentration of rats submitted to carrageenan (CARR)-induced (0.3 mg/kg) peritonitis. Data expressed as mean ± SEM (n = 5–6/group). ++ p < 0.01 vs. white group; * p < 0.05 vs. CARR group. Kruskal–Wallis followed by Dunn’s test.
Figure 4. Effect of Aniba canelilla essential oil (AcEO; 2.0 and 5.0 mg/kg; ip.) on peritoneal fluid GSH concentration of rats submitted to carrageenan (CARR)-induced (0.3 mg/kg) peritonitis. Data expressed as mean ± SEM (n = 5–6/group). ++ p < 0.01 vs. white group; * p < 0.05 vs. CARR group. Kruskal–Wallis followed by Dunn’s test.
Antioxidants 11 01903 g004
Antioxidants 11 01903 g005 550
Figure 5. Effect of Aniba canelilla essential oil (AcEO; 2.0 and 5.0 mg/kg; ip.) on thiobarbituric acid reactive substances (TBARS) level in (A) peritoneal fluid and (B) plasma of rats submitted to carrageenan (CARR)-induced (0.3 mg/kg) peritonitis. Data expressed as mean ± SEM (n = 5–6/group). +++ p < 0.001 vs. white group; ** p < 0.001 vs. CARR group; *** p < 0.001 vs. CARR group. One-way ANOVA followed by Dunnett’s test.
Figure 5. Effect of Aniba canelilla essential oil (AcEO; 2.0 and 5.0 mg/kg; ip.) on thiobarbituric acid reactive substances (TBARS) level in (A) peritoneal fluid and (B) plasma of rats submitted to carrageenan (CARR)-induced (0.3 mg/kg) peritonitis. Data expressed as mean ± SEM (n = 5–6/group). +++ p < 0.001 vs. white group; ** p < 0.001 vs. CARR group; *** p < 0.001 vs. CARR group. One-way ANOVA followed by Dunnett’s test.
Antioxidants 11 01903 g005
Antioxidants 11 01903 g006 550
Figure 6. Effect of Aniba canelilla essential oil (AcEO; 2.0 and 5.0 mg/kg; ip.) on peritoneal fluid protein concentration of rats submitted to carrageenan (CARR)-induced (0.3 mg/kg) peritonitis. Data expressed as mean ± SEM (n = 5–6/group). +++ p < 0.001 vs. white group; *** p < 0.001 vs. CARR group; ** p < 0.01 vs. CARR group. One-way ANOVA followed by Dunnett’s test.
Figure 6. Effect of Aniba canelilla essential oil (AcEO; 2.0 and 5.0 mg/kg; ip.) on peritoneal fluid protein concentration of rats submitted to carrageenan (CARR)-induced (0.3 mg/kg) peritonitis. Data expressed as mean ± SEM (n = 5–6/group). +++ p < 0.001 vs. white group; *** p < 0.001 vs. CARR group; ** p < 0.01 vs. CARR group. One-way ANOVA followed by Dunnett’s test.
Antioxidants 11 01903 g006
Antioxidants 11 01903 g007 550
Figure 7. Effect of Aniba canelilla essential oil (AcEO; 2.0 and 5.0 mg/kg; ip.) on peritoneal fluid number of leukocytes of rats submitted to carrageenan (CARR)-induced (0.3 mg/kg) peritonitis. Data expressed as mean ± SEM (n = 3–5/group). +++ p < 0.001 vs. white group; ** p < 0.01 vs. CARR group; * p < 0.05 vs. CARR group. One way ANOVA followed by Dunnett’s test.
Figure 7. Effect of Aniba canelilla essential oil (AcEO; 2.0 and 5.0 mg/kg; ip.) on peritoneal fluid number of leukocytes of rats submitted to carrageenan (CARR)-induced (0.3 mg/kg) peritonitis. Data expressed as mean ± SEM (n = 3–5/group). +++ p < 0.001 vs. white group; ** p < 0.01 vs. CARR group; * p < 0.05 vs. CARR group. One way ANOVA followed by Dunnett’s test.
Antioxidants 11 01903 g007
Table
Table 1. Chemical composition of Aniba canelilla essential oil.
Table 1. Chemical composition of Aniba canelilla essential oil.
RI(C)RI(L)Compounds% *
850850 a3Z-hexenoltr
933932 aα-pinene0.4 ± 0.3
958952 abenzaldehyde0.6 ± 0.4
977974 aβ-pinene0.4 ± 0.3
10241020 ap-cymene0.1 ± 0.0
10281024 alimonene0.2 ± 0.2
10311026 a1,8-cineole0.1 ± 0.1
10411036 abenzene acetaldehyde1.1 ± 0.1
11001095 alinalool2.8 ± 0.7
11371134 abenzeneacetonitrile0.2 ± 0.1
11901186 aα-terpineol0.4 ± 0.1
11951195 amyrtenal0.1 ± 0.0
13081294 a1-nitro-2-phenylethane77.5 ± 4.8
13571356 aeugenol0.3 ± 0.1
13771374 aα-copaene0.8 ± 0.4
14081417 aβ-longipinene1.6 ± 0.9
14201417 aE-caryophyllene3.6 ± 2.7
14541452 aα-humulene0.4 ± 0.3
14961498 aα-selinene0.1 ± 0.0
15091505 aβ-bisabolene0.1 ± 0.0
15251522 aδ-cadinene0.1 ± 0.1
15841582 acaryophyllene oxide4.4 ± 0.9
16101608 ahumulene epoxide II0.3 ± 0.1
16341639 acaryophyll-4(12),8(13)-dien-5-α-ol0.2 ± 0.0
16371639 acaryophyll-4(12),8(13)-dien-5-β-ol0.7 ± 0.1
16561658 aselin-11-en-4-α-ol0.8 ± 0.0
16721668 a14-hydroxy-9-epi-E-caryophyllene0.2 ± 0.2
monoterpene hydrocarbons1.0 ± 0.9
oxygenated monoterpenes3.5 ± 1.0
sesquiterpene hydrocarbons6.9 ± 4.7
oxygenated sesquiterpenes6.9 ± 1.6
benzenoids80.0 ± 5.8
Total identified98.4
* = mean ± standard deviation (n = 3); RI(C) = calculated retention index on Rtx-5ms capillary column; RI(L) = literature retention index, a = (Adams, 2007), tr = traces (<0.1%).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Cardoso, E.K.S.; Kubota, K.; Luz, D.A.; Mendes, P.F.S.; Figueiredo, P.L.B.; Lima, R.R.; Maia, C.S.F.; Fontes-Júnior, E.A. Aniba canelilla (Kunth) Mez (Lauraceae) Essential Oil: Effects on Oxidative Stress and Vascular Permeability. Antioxidants 2022, 11, 1903. https://doi.org/10.3390/antiox11101903

AMA Style

Cardoso EKS, Kubota K, Luz DA, Mendes PFS, Figueiredo PLB, Lima RR, Maia CSF, Fontes-Júnior EA. Aniba canelilla (Kunth) Mez (Lauraceae) Essential Oil: Effects on Oxidative Stress and Vascular Permeability. Antioxidants. 2022; 11(10):1903. https://doi.org/10.3390/antiox11101903

Chicago/Turabian Style

Cardoso, Eloise K. Serrão, Karen Kubota, Diandra Araújo Luz, Paulo Fernando S. Mendes, Pablo Luis B. Figueiredo, Rafael Rodrigues Lima, Cristiane S. Ferraz Maia, and Enéas Andrade Fontes-Júnior. 2022. "Aniba canelilla (Kunth) Mez (Lauraceae) Essential Oil: Effects on Oxidative Stress and Vascular Permeability" Antioxidants 11, no. 10: 1903. https://doi.org/10.3390/antiox11101903

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop